They do raise some of these concerns in the paper and the need for a larger study etc. they say they have tests using this tech in use for prostate cancer and predicting response to checkpoint inhibitors. So I’d like to assume they have some idea of what they are doing. Wishful thinking of a non...
Have mixed feelings about this paper. Credit where it is due - clearly a lot of science went into making it, that no one else was prepared/able to do. But it appears we have not got much (at least immediately) in terms of findings out of it. Nath has mentioned there are other papers to come...
Trial details - mestinon and/or LDN
https://www.omf.ngo/lift-trial/
This post has been copied and discussion moved to:
The LIFT trial (OMF) - Pyridostigmine (mestinon) and Low Dose Naltrexone (LDN)
Prusty's talk at the Invest in ME conference 2023 is titled:
Herpesvirus reactivation as a trigger for mitochondrial dysfunction in ME/CFS
http://www.investinme.org/IIMEC15.shtml#about
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.